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Abstract
Nosocomial pathogens such as Methicillin-Resistant Staphylococcus aureus
(MRSA) and Vancomycin-resistant Enterococci (VRE) are the cause of signif-
icant morbidity and mortality among hospital patients. It is important to be
able to assess the efficacy of control measures using data on patient outcomes.
In this paper we describe methods for analysing such data using patient-level
stochastic models which seek to describe the underlying unobserved process of
transmission. The methods are applied to detailed longitudinal patient-level
data on VRE from a study in a US hospital with eight intensive care units
(ICUs). The data comprise admission and discharge dates, dates and results of
screening tests, and dates during which precautionary measures were in place
for each patient during the study period. Results include estimates of the effi-
cacy of the control measures, the proportion of unobserved patients colonized
with VRE and the proportion of patients colonized on admission.
keywords: Antimicrobial resistance; Bayesian methods; Healthcare-associated infec-
tions; MRSA; VRE
1 Introduction
The emergence of antimicrobial-resistant pathogens such as Methicillin-Resistant
Staphylococcus aureus (MRSA) and Vancomycin-resistant Enterococci (VRE) dur-
ing the past two decades is a major clinical and epidemiological problem throughout
the world. Understanding these pathogens and assessing methods for their control
∗Corresponding author: Yinghui Wei, Centre for Mathematical Sciences, Plymouth University,
PL4 8AA, UK. Email: yinghui.wei@plymouth.ac.uk.
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continues to be an area of considerable importance (see e.g. [8, 16, 18] and references
therein). In this paper we describe methods for analysing longitudinal patient-level
hospital data on nosocomial pathogens. The methods involve defining stochastic mod-
els which describe how the pathogen spreads between individual patients. Specifically,
we build on the methods of [17] in which data on MRSA were analysed, and extend
this approach to data on VRE. The focus of the earlier paper was towards clinical
results, and in particular there was no detailed description of the statistical methods
used. In contrast, here we fully describe these methods, and also develop methods
for model comparison and model assessment which were not in the earlier work.
The kind of data we consider typically consist of admission and discharge times for
each patient on a hospital ward, along with the times and results of screening tests
for the pathogen in question. There may also be other information, such as the times
and types of infection control measures administered, or treatments. Such data are
characterized by two aspects, namely that they are highly dependent (e.g. whether
or not a patient is colonized with the pathogen in question depends on the status of
other patients) and that the process which generates the data, namely transmission,
is unobserved. This in turn implies that standard statistical methods for longitudinal
data such as time-series methods or survival analysis methods are not usually natural
in this setting. Instead, modelling methods are more appropriate.
Various modelling approaches to analysing longitudinal epidemiological data on hos-
pital pathogens have been developed, typically applied to data on MRSA. These
include fitting deterministic models ([1]), maximum-likelihood methods applied to
Markov chain models [23, 3, 10], hidden Markov models [20], and non-parametric
approaches for Markov process models [29]. All of these methods involve simplifying
assumptions of one kind or another which can be relaxed by using individual-level
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stochastic models and a Bayesian framework. The latter approach, using Markov
chain Monte Carlo (MCMC) methods, is taken in [12, 17] essentially by developing
the ideas in [14, 21]. This is the approach that we adopt in this paper. Since the un-
derlying models essentially describe the unobserved process of transmission between
patients, the MCMC methods involve augmenting the observed data with the trans-
mission events themselves. The appeal of this approach is that it is highly flexible,
it usually avoids the need for simplifying assumptions which are common in other
methods, and can provide much richer inferential information from the data than
maximum likelihood methods.
In this paper we analyse data on VRE, which are bacteria from the genus Entero-
coccus which have acquired resistance to Vancomycin. Enterococci also have intrinsic
resistance to several classes of antibiotics. They usually live harmlessly within the
gastrointestinal tract or on the skin, but can cause infections, especially among those
with weakened immune systems. In consequence, they can produce disease in highly
vulnerable hospital patients, such as those in oncology wards or intensive care units
(ICUs). Changes in resistance patterns over time frequently mean that VRE strains
are resistant to most antimicrobial agents. VRE have been endemic in hospital set-
tings in Europe and the USA since the start of the 21st century, and are a major
problem in healthcare settings throughout the world. In such environments, trans-
mission of VRE between patients is believed to occur indirectly, largely via health
care workers and in particular by contamination of hands or gloves [4, 2]. Environ-
mental contamination is also thought to be a possible transmission route. For this
reason, control strategies typically focus on activities such as hand-washing, barrier
precautions (glove and gown use), and environmental cleaning.
The paper is structured as follows. The data structure and transmission models are
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described in sections 2 and 3, respectively. The MCMC methods are introduced in
section 4 and applied to the VRE data in section 5. We finish with some discussion
in section 6.
2 Data structure
The individual patient data are taken from a 17-month longitudinal study in a hospital
in Boston, USA, involving over 8,000 patients who were admitted to one of eight
different ICUs during the study period. The data consist of the dates on which each
patient was admitted and discharged from the ICU, the dates and results of any
screening tests that took place, and any dates during which the patient was placed
under precautionary measures due to their being supposed to be colonized with VRE.
The precautionary measures consisted of glove and gown use by healthcare workers,
and the use of isolation rooms, and were the same for all patients concerned. Such
data contain many inherent dependencies: for instance, whether or not a patient
becomes colonized could reasonably be supposed to depend on the number of other
currently-colonized patients in the ICU. For this reason it is natural to analyse such
data using a model-based approach which explicitly describes how the pathogen can
spread between patients over time.
Each patient may undergo a number (possibly zero for some patients) of screening
tests, the results of which are either positive (denoting colonization with the pathogen)
or negative. Note that we take colonization to mean either asymptomatic carriage
(i.e. the pathogen is present in the body but has not caused clinical infection) or
infection, and we do not distinguish between these two states. Furthermore, for
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VRE the amount of pathogen shed by carriers or those infected is usually similar,
which further motivates this modelling assumption. Each patient may also be placed
in isolation during their stay in the ward, usually as a result of a positive test, or
for other clinical reasons. The exact meaning of isolation depends on the study in
question, examples including physical isolation in a single room, use of additional
barrier precautions, etc. The models we describe below assume that only one kind of
isolation is adopted, although it would be straightforward to relax this assumption.
3 Models
The data set of interest comprises eight different ICU wards. We analyse the data
from each ICU separately. This is motivated by the fact that the ICUs have different
kinds of patients (e.g. medical/surgical) and so there is no reason to suppose that
parameters governing VRE transmission are common across all wards. Furthermore,
relatively few patients were admitted to more than one of the ICUs.
In the following, we describe modelling approaches for data on patients in a single
ICU. The study period begins and ends at times TS and TE , respectively. During
the study period, the admission and discharge times of all patients on the ward are
recorded. Patients already present in the ward at time TS are deemed to have been
admitted at TS, and those in the ward at TE are deemed to have been discharged at
TE . Patients might be re-admitted during the study period.
We consider three models for colonization, with the following common assumptions.
First, at each point in time every patient in the ward is either susceptible or colonized,
and can be either in or out of isolation. Second, the test results are assumed to have
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perfect specificity (so that a positive test result can only arise if the patient really
is colonized), and sensitivity p × 100% (so a colonized patient has probability p of
testing positive). The assumption of perfect specificity is natural in the setting we
consider, since screening tests are usually culture-based, and false positives can only
arise via the rare event of contamination [24]. However, this assumption can be easily
relaxed within our framework.
Third, if a patient has a positive test, then they are assumed to remain colonized for
the following six months [15, 25, 27]. In particular, if a patient is re-admitted within
six months of a positive test, then they are said to be colonized on re-admission at
the time of re-admission, and assumed to remain colonized until next discharged.
Conversely, if a patient is admitted to the ward with no positive test result during
the previous six months, which in many cases is simply because they have never been
previously admitted at all, then they are called a new admission at the time of ad-
mission. Each new admission has a probability φ of being colonized on admission,
independently of all other patients and admissions. We refer to φ as the importa-
tion probability. New admissions are also formally regarded in the model as being
new patients, even if they have been previously admitted. In particular, the term
patient should be interpreted in this way in this section and the next. Although the
assumption that the same individual can be formally treated as two patients is made
largely for simplicity, it is often pragmatic in practice unless there are a large number
of re-admissions in the data.
The final component of the model is the mechanism for potential colonization of pa-
tients who are not already colonized. We adopt the usual assumption from stochastic
disease transmission modelling that susceptible individuals are colonized according
to a Poisson process whose rate might depend on the numbers of existing colonized
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patients within the ward. In the context of nosocomial pathogens, the transmission
between patients is usually indirect, typically via healthcare workers or the environ-
ment. We refer to patients who are colonized in this way as colonized on the ward.
Specifically, each susceptible patient is, independently of other susceptibles, assumed
to be colonized at a time corresponding to the first point of a non-homogeneous
Poisson process of rate λ(t) ≥ 0 at time t. We consider three possible models for
λ(t). In order to investigate the effectiveness of control measures, in each model we
differentiate between isolated and non-isolated patients.
Full model. This model is defined in [12] and assumes that
λ(t) = β0 + β1C(t) + β2Q(t)
where Q(t) and C(t) denote the number of colonized patients on the ward at time t
who are in and out of isolation, respectively. Here β0 represents a background rate of
colonization which is unaffected by the current prevalence on the ward, for instance
arising due to medical staff who service many wards and may act as vectors for the
pathogen. Conversely, β1 and β2 represent rates attributed to colonized patients.
This way of modelling transmission is a natural generalization of the usual mass-
action assumption in standard epidemic models such as the SIR (susceptible-infective-
removed) epidemic model (see e.g. [21]), which has itself been extensively used to
successfully describe pathogen transmission in many different settings. Specifically,
our approach assumes that each colonized individual with the same isolation status
(in or out) makes an equal and independent contribution to the overall colonization
rate. This is a very natural assumption with a clear epidemiological interpretation,
and also avoids the need to specify more complex dependencies between individuals.
No-background transmission model. This model is a special case of the full model
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in which β0 is assumed to be close to zero with high probability. In practice this is
achieved by assigning a suitable prior distribution to β0, as discussed below. This
model represents the hypothesis that transmission almost always occurs due to the
presence of colonized patients in the ward. As well as being of interest in its own right,
considering this model also allows us to assess the impact of assuming background
transmission.
Non-linear model. This model assumes that it is only the presence of colonized
patients, not their number, which affects the rate of new colonizations. In particular
it is not assumed that λ(t) is linear in C(t) and Q(t), as in the full model. Such a
model is suitable if the amount of pathogen in the ward from one patient is so great
as to have a saturation effect. Specifically,
λ(t) = β0 + β1χ{C(t)>0} + β2χ{Q(t)>0},
where χA denotes the indicator function of the event A. In some sense this model
provides an extreme alternative to the mass-action type assumptions in the previous
models, since now there is no increase in colonization rate as the numbers of colonized
individuals increase beyond one.
4 Inference methods
4.1 Notation and likelihoods
Let θ = (p, φ, β0, β1, β2) denote the vector of model parameters. We denote all data
(admission and discharge times, times and outcomes of test results, times of patient
isolation) by y, although as explained above we only have a probability model for the
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colonization process and test sensitivity. Adopting a Bayesian framework, our objec-
tive is to explore the posterior density pi(θ|y). Now the likelihood pi(y|θ) is intractable
in practice, since its evaluation involves integrating over all possible unobserved col-
onization times (cf. [21], for the analagous situation for standard epidemic models).
Consequently, we augment the parameter space to include all colonization times, c
say.
Under the assumption of perfect test specificity, c includes the unobserved colonization
time for each patient who ever has a positive test result. Additionally, individuals
who do not have a positive test result may still be colonized, their undetected status
arising either because they never had a test at all, or because any test was a false
negative. The colonization times of such individuals are also included in c. Note
also that c is also assumed to describe which patients are colonized on admission and
which are colonized on re-admission.
By Bayes’ Theorem,
pi(θ, c|y) ∝ pi(y, c|θ)pi(θ),
where pi(θ) denotes the prior density of θ. It remains to evaluate the augmented
likelihood pi(y, c|θ). Let nA denote the number of new admissions and nCA denote
the number of these who are colonized on admission. Note that nA is determined
by the data y, but nCA is determined by both y and c. Define nTP and nFN as
the number of true positive and false negative test results. Under the assumption of
perfect specificity, nTP is determined by y. Conversely, since sensitivity need not be
perfect, nFN is determined by y and c.
Define K as the set of patients who are colonized on the ward. For a typical patient
in K, denoted j say, define nC(j) and nQ(j) as the numbers of patients who are
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respectively colonized and not isolated, and colonized and isolated, at the time of j’s
own colonization. Note that K, nC(j) and nQ(j) can all be determined from y and c,
but none are known explicitly from just y.
The augmented likelihood for the full model takes the form
pi(y, c|θ) ∝ φnCA(1− φ)nA−nCA × pnTP (1− p)nFN
×
∏
j∈K
(β0 + nC(j)β1 + nQ(j)β2)
× exp
{
−
∫ TE
TS
(β0S(t) + β1C(t)S(t) + β2Q(t)S(t)) dt
}
, (1)
where S(t) denotes the number of susceptible patients on the ward at time t. The
likelihood can be derived as follows. First, the terms involving φ account for the
probability of nCA patients being colonized on admission and the remaining nA−nCA
being not colonized on admission. Second, the terms involving p give the probability
of observing the true positive and false negative test results. Note that since we keep
track of each individual patient, for both the φ and p expressions we do not require
any combinatorial terms; for instance, we know exactly which patients are colonized
on admission, not just the number.
The remaining part of the likelihood arises from the colonization process. Recall that
if a non-homogeneous Poisson process with rate ξ(t) at time t is observed during a
time interval [0, T ], and m points occur at times 0 ≤ t1 < t2 < . . . < tm ≤ T , the
likelihood is given by (
m∏
i=1
ξ(ti−)
)
exp
{
−
∫ T
0
ξ(t) dt
}
, (2)
where ξ(ti−) denotes the rate just before time ti, see for example [9], Chapter 7. The
product term accounts for the points occurring and the exponential term accounts
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for the absence of points at other times. In our setting, each susceptible patient
is colonized according to a Poisson process of rate λ(t) = β0 + β1C(t) + β2Q(t) at
time t ≥ 0, and so the overall colonization process (i.e. the process which counts
colonization events but does not specify which individuals are actually colonized) is a
Poisson process of rate S(t)λ(t). Setting ξ(t) = S(t)λ(t) in (2) gives the likelihood of
this overall colonization process. However, we also know the identity of each colonized
patient, and since each susceptible patient is equally likely to be colonized at any given
time, the probability that a particular patient is colonized is 1/S(t). Incorporating
this probability into the product term in (2) yields the product term in (1). Finally,
the likelihood in (1) can also be derived and expressed by purely thinking in terms
of individual patients, which results in the integral being expressed as a sum over
patients, see [12].
It is straightforward to modify (1) to obtain the corresponding likelihoods for the
no-background and non-linear models. Finally, we assign independent Beta prior
distributions to p and φ, and independent exponential prior distributions to the col-
onization rate parameters β0, β1 and β2.
4.2 Markov Chain Monte Carlo algorithm
In order to explore pi(θ, c|y) we use a Metropolis-Hastings MCMC algorithm which
updates the elements of θ and the unknown colonization times c, as follows. First,
it follows from (1) and our choice of prior distributions that both p and φ have
Beta-distributed full conditional distributions, and hence can be updated according
to Gibbs steps. Second, the colonization rate parameters β0, β1 and β2 can all be
updated using a Gaussian random walk, where proposed negative values are rejected
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immediately since the proposed likelihood is zero.
Third, updates for the colonization times c are achieved via three possible steps,
one of which is chosen uniformly at random during each iteration of the MCMC
algorithm. Recall that patients who are colonized on re-admission are assumed to
have a colonization time equal to their time of admission. Since such re-admissions
are determined directly by the data, the colonization times in question are never
updated in the MCMC algorithm.
Of the remaining patients, those with a positive test result are assumed to be definitely
colonized, and such patients therefore always have a colonization time. Denote the set
of such patients P and note that P is determined by the data y. All other remaining
patients may or may not be colonized; denote the set of those currently colonized by
N1 and those not by N0. Thus P, N0 and N1 have no intersection and their union is
the set of all patients other than those colonized on re-admission. Let n0, n1 and np
denote the number of patients in N0, N1 and P, respectively.
The three possible steps involved in updating the colonization times are as follows. We
define aj , dj and cj as the admission, discharge and colonization times, respectively,
of individual j.
1. Adding a colonization time: an individual j is selected randomly fromN0. With
probability φ0, j is proposed to be colonized on admission, so cj = aj ; otherwise
cj is sampled uniformly from (aj , dj). Denoting c˜ as the proposed new c with
cj added, the move is accepted with probability
n0(dj − aj)pi(θ, c˜|y)
(1− φ0)(n1 + 1)pi(θ, c|y)
∧ 1
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if cj ∈ (aj, dj), and
n0pi(θ, c˜|y)
φ0(n1 + 1)pi(θ, c|y)
∧ 1
if cj = aj , where x ∧ y denotes min(x, y).
2. Deleting a colonization time: an individual j is randomly selected from N1, and
its colonization time cj is removed from c with probability
(1− φ0)n1pi(θ, c˜|y)
(n0 + 1)(dj − aj)pi(θ, c|y)
∧ 1
if cj ∈ (aj, dj), and
φ0n1pi(θ, c˜|y)
(n0 + 1)pi(θ, c|y)
∧ 1
if cj = aj , where c˜ denotes c with cj removed.
3. Moving a colonization time: randomly select an individual j from N1∪P. With
probability φ0, set the proposed new colonization time as c˜j = aj ; otherwise, c˜j
is sampled uniformly from (aj , tj), where tj = dj if j ∈ N1 and tj is the time of
j’s first positive test if j ∈ P. Thus the proposal density of c˜j is
q(c˜j |cj) = q(c˜j) =


φ0
n1+np
if c˜j = aj ,
1−φ0
(n1+np)(tj−aj)
if c˜j ∈ (aj , tj).
The new colonization time c˜j is accepted with probability
pi(θ, c˜|y)q(cj|c˜j)
pi(θ, c|y)q(c˜j|cj)
∧ 1,
where c˜ denotes c with cj replaced by c˜j.
4.3 Model assessment
Although our main focus is not to formally distinguish between competing models,
it is nevertheless of interest to perform a comparison. There is no canonical method
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to do this in our setting, and different approaches have their own pros and cons. For
simplicity, we used a form of deviance information criterion (DIC, [26]). Since our
setting involves missing data (namely, the unobserved colonization times) we require
a form of DIC which takes this into account, and moreover which can be readily
calculated. We therefore used DIC6 from [6] defined by
DIC6 = −4Eθ,c[log pi(y, c|θ)] + 2Ec[log pi(y, c|θˆ(y))|y, θˆ(y)], (3)
where pi(y, c|θ) is given by (1) and we set θˆ(y) to be the posterior mean of θ, as
estimated from our MCMC algorithm. In practice, DIC6 can be easily evaluated
using MCMC output as described in [6]. Although we used DIC6 for convenience,
it has been explored in a similar context to ours by [30] who found that it can be
effective provided there are sufficient data available.
We also consider two forms of model assessment, i.e. methods for exploring how
well each model fitted the observed data. The first of these is a posterior predictive
p-value [13] to assess the model fit to data, specifically with the total number of
detected colonizations as the discrepancy statistic to measure the difference between
the observed and simulated data. To implement this method, the model parameters
in question are first repeatedly sampled from their posterior distribution, i.e. from
the MCMC output. In practice we take every 100th sample from the chain. For
each sampled set of parameter values, the model is then simulated forward in time
to produce a possible realisation. We then calculate a p-value as the proportion of
simulations in which the total number of detected colonizations is greater or equal to
that in the observed data. A p-value close to 0.5 indicates a good fit to the data. In
contrast, an extreme p-value (p > 0.95 or p < 0.05) indicates that the fitted model is
not appropriate for the data.
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The second method of model assessment is to consider the predictive distribution of
the number of detected colonizations through time. This is implemented by again
sampling parameters from the posterior distribution and simulating the model forward
in time for each set of parameter values to produce a large number of realisations of
the whole process. We then graphically compare the observed data with the mean
and quantiles of the set of simulated realisations.
5 Application to data
5.1 Data
The data we consider were collected from eight 10-bed ICUs in a tertiary academic
medical center in Boston, Massachusetts over a 17-month period. The ICUs comprised
two medical wards (which we denote M1, M2), two general surgical wards (GS1, GS2),
and four specialty surgery wards (SS1-SS4). Routine rectal admission and weekly
screening was carried out using swab tests, with compliance around 90%. In addition
there was a protocol in which patients who were identified as being VRE-positive were
placed under contact precautions which consisted of gown and glove use by healthcare
workers, and use of single rooms.
Figure 1 shows the number of first detected colonizations and total current detected
colonizations for one of the wards (medical ward M1) on a weekly basis during the
observation interval. Descriptive statistics of the individuals in ICUs are shown in
Table 1. The relatively high values for the standard deviation of length of stay reflect
the fact that ICU patients typically have either quite short or quite long stays. The
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median length of stay was around 3-6 days. On most wards, patients have just over
one swab test on average, and thus there are many patients in the data set with only
one (usually admission) swab test. Finally, around 5-10% of all patients in the study
were re-admitted during the study period.
[Table 1 about here.]
[Figure 1 about here.]
5.2 Algorithm implementation
Before considering the data at hand, we first simulated data sets from each of the true
models and then used our MCMC algorithm to estimate the model parameters. The
results indicated that our methods could recover the true parameter values reasonably
well. The MCMC algorithm was then implemented separately for the eight wards
for each of the three models under consideration, and the DIC values computed.
The model parameters were assigned uninformative independent prior distributions.
Specifically, φ, p ∼ U(0, 1) and β0, β1, β2 ∼ Exp(10−6) where Exp(λ) denotes an
exponential distribution with mean λ−1, with the exception that β0 ∼ Exp(106) in
the no-background model. The algorithm was implemented by using Microsoft Visual
C++ 2010 Express software with double precision and the GSL Scientific Library. The
C++ code is available upon request from the first author.
5.3 Results
Parameter estimates. Posterior medians of the model parameters are shown in Table
2. Estimates of both the importation probability φ and the test sensitivity p appear
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robust to the choice of model, and both parameters are estimated with reasonable
precision. The importation probability is generally in the range 5-15% other than
medical ward M2 where it exceeds 20%. The test sensitivity is around 70% or higher,
with the striking exception of general surgery ward GS2, where it is around 50%.
These values for φ and p are both reasonable in clinical terms.
The transmission rate parameters estimates exhibit clear variation between the mod-
els, which is to be expected due to the differences of the model assumptions them-
selves. The posterior standard deviations are typically of the same order as the
posterior median values, illustrating that there is reasonable uncertainty in the pos-
terior estimation of β0, β1 and β2. This uncertainty is essentially a consequence of the
prevalence of VRE (discussed below): the majority of patients never have a positive
test which makes it harder to estimate transmission rate parameters accurately.
The background rate β0 is (in the full and non-linear models) invariably estimated to
be higher than β1 and β2, often around twice as much or more. This can be interpeted
as saying that the background colonization rate is roughly equivalent to that due to
two or three colonized patients on the ward. Regarding estimation of such rates,
note that any colonization event which occurs whilst the ward contains no colonized
patients must be attributable to the background rate, whereas colonization events
that occur with (as is typical) one or two colonized patients in the ward could be
due to background or transmission events. Thus it is possible that, if we explicitly
modelled the ‘source’ of each colonization event, more colonizations than not would
be background colonization events.
[Table 2 about here.]
Unobserved carriage. Unobserved carriage arises in two ways, namely false negative
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test results, or colonization which occurs before any test is carried out. Thus unob-
served carriage is a function of both the test sensitivity and the frequency of testing.
Our transmission models explicitly include all unobserved colonization events, and
so in particular it is possible for individuals to be colonized but undetected. The
inference methods enable us to estimate the extent of this unobserved colonization
directly. Table 3 shows the observed mean monthly prevalence of VRE, calculated
directly from the positive test results in the data, and the median posterior prevalence
as predicted by the full model (other models gave similar results). It appears that
the observed prevalence accounts for just over half of the predicted prevalence.
[Table 3 about here.]
It is possible to derive more complex quantities which describe the extent of unob-
served carriage. In particular, we define Phidden as the proportion of all colonized-
patient-days which are unobserved in the sense that a patient is colonized but not
under precautions, and Pwait as the proportion of all colonized-patient-days during
which a patient is pending knowledge of a positive test result and has yet to be placed
under precautions. Denote pj as the precaution time of individual j, with pj = ∞
for an individual never placed under precautions, recall that tj is the time of j’s first
positive test and set tj =∞ if j never has a positive test. It follows that
Phidden =
∑
j:cj∈[aj ,dj ]
([(pj ∧ dj)− cj] ∨ 0)∑
j:cj∈[aj ,dj ]
(dj − cj)
, Pwait =
∑
j:pj∈[tj ,dj ]
(pj − tj)∑
j:cj∈[aj ,dj ]
(dj − cj)
,
where ∧ and ∨ denote min and max, respectively. To see that Pwait cannot exceed
1, note that any j in the numerator sum has tj < ∞, and under the assumption of
perfect specificity aj ≤ cj ≤ tj , and thus j also appears in the denominator sum.
[Figure 2 about here.]
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Figure 2 gives posterior median values of Phidden and Pwait for all three models. The
values appear to be robust across the models themselves. The apparently high values
of Phidden are not surprising in view of the predicted prevalence values; in particular,
each individual who is colonized but never placed under precautions contributes the
entire duration of their colonization to the numerator of Phidden. Conversely, the low
Pwait values indicate that patients who were detected were placed under precautions
swiftly.
Efficacy of precaution measures. The efficacy of the precaution measures in reducing
transmission may be evaluated by comparing the rate of β1 and β2, with β1 greater
than β2 indicating a positive benefit. We specifically consider the posterior proba-
bility P (β1 > β2|y) and the posterior median value of β1/β2, as given in Figure 3.
From these values, there is no compelling evidence to support the effectiveness of
the precaution measures. The probability P (β1 > β2|y) varies widely between wards,
only once exceeding 0.8 (ward GS1) and with most values in the range 0.45-0.65. One
exception is the specialty surgery ward SS1 which has values of 0.16 and 0.08, provid-
ing some evidence to suggest that precaution measures had a negative impact under
the assumptions of the models in question (full model and no-background model).
The log(β1/β2) values give very similar conclusions, and in particular posterior point
values obtained by pooling estimates across all wards (using the inverse variance
method as described in [28] (section 5.2) are all close to unity for each model. How-
ever, the posterior credible intervals for log(β1/β2) indicate a high degree of posterior
uncertainty for this quantity, which is most likely inherited from the high posterior
variances for β1 and β2.
[Figure 3 about here.]
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Model assessment. The posterior predictive p-values are given in Figure 4. There is
no strong evidence to suggest that the fitted models are inappropriate for the data,
with one exception of ward SS3. Based on the p-values, there is no clear indication
that any model is preferred over the others.
Figures 5-7 show the comparison between simulated and the observed epidemic data
based on the number of detected colonizations at 14-days intervals. The figures
indicate that the number of detected colonizations are reasonably well approximated
by the simulated realisations, although the models can fail to capture the occasional
more extreme fluctuations in the data. Overall there is no clear indication that one
model is to be preferred.
[Figure 4 about here.]
[Figure 5 about here.]
[Figure 6 about here.]
[Figure 7 about here.]
Model comparison. DIC values are given in table 4. It is notable that the no-
background model is preferred in the medical and general wards, although in some
cases the full model DIC values are very similar. This suggests that the risk of new
colonization events increases with the number of existing colonized patients. In con-
trast, for all of the specialty surgery wards the non-linear model is favoured. This
suggests that it is the presence of colonized patients, rather than the number, that is
the driving force behind new colonizations in these wards.
[Table 4 about here.]
Sensitivity analysis. In our primary analysis we have used Exp(10−6) (mean 106, vari-
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ance 1012) as the prior distribution for each of β0, β1 and β2. In particular, this means
that the prior density for these parameters is relatively flat in the region of interest,
and so we expect the prior to have little impact on the posterior distributions. To
explore this assumption, we conducted a sensitivity analysis by first using Exp(10−3)
prior distributions, and then Exp(10−12) prior distributions. In both cases, the pos-
terior estimates of model parameters were found to be very similar to those in the
original analysis.
We have assumed that patients remained colonization for six months after they be-
came colonized. We assessed the impact of this assumption on the posterior distri-
bution by assuming that patients remained colonized for three months. Again, the
results obtained were very similar to those in the original analysis.
6 Discussion
We finish by discussing the results of the analysis of the VRE data set, and then
general comments on our methods.
6.1 VRE study
Our results show that almost half of VRE prevalence was unobserved. This was true
despite high compliance admission rectal swabs for these ICU patients, suggesting
that a single swab is insufficient for adequate sensitivity, as has been previously sug-
gested [7]. In addition, despite the fact that weekly rectal screening for VRE was
the standard of care in these ICUs, the short average length-of-stay meant that most
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patients only received one swab. Relatively high prevalence values are not unknown;
for instance [5] reports that about 70% of swabs were found to be positive during a
study in a UK haematology ward, while the prevalence estimated by [1] also reaches
70%. Furthermore, neither of these studies took into account imperfect swab test
sensitivity as we have done.
For the full and non-linear models we found that the background rate of colonization
(β0) was typically two to three times higher of that the colonization rates attributed to
colonized patients (β1, β2), meaning that the background rate was roughly equivalent
to that due to two or three colonized patients on the ward. Background contamination
is believed to be a possible route of VRE transmission [2, 11, 19] and these findings
give no evidence to the contrary. However, some care is needed in interpreting β0
within our models, since it effectively models any colonization potential which is not
associated with colonized patients in the ward, and in particular is not restricted to
environmental contamination alone. We also found some pattern in the DIC values
in table 4, suggesting different kinds of transmission in the specialty surgery wards
compared to the other wards.
We found no evidence to suggest that the use of barrier precautions was effective
in reducing colonization. Broadly speaking, the colonization rates attributable to
patients placed under precautions were not significantly different to the colonization
rates attributable to patients who were not under precautions. One plausible expla-
nation is that the barrier precautions really were not discernably more effective than
standard procedures, especially given that at any one time there might only be one
or two colonized patients on the ward, making any true difference hard to detect.
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6.2 Methods
We have described model-based methods for analysing patient-level data on noso-
comial pathogens. The methods work at an individual level by explicitly keeping
track of the status of each patient and assuming a mechanism by which patients
may become colonized with the pathogen in question. One appealing aspect of this
kind of modelling is that it is often straightforward to adapt it to include additional
model features, as motivated by both the available data and the scientific questions
of interest.
Our methods involved data augmentation, essentially providing estimates of quanti-
ties that are not directly observed. Although this was primarily motivated by the
fact that such missing data enable us to calculate a likelihood, the fact that the miss-
ing data (namely, colonization times) correspond to real-life events mean that they
can be exploited to provide further information. In our application we used them to
estimate quantities that describe the impact of unobserved carriage.
We have considered three possible models for the colonization process, based on
widely-used natural assumptions for how the numbers of susceptible and colonized
individuals affect the rate of new colonizations. Our purpose in doing so was to both
explore the impact of particular assumptions regarding colonization, and to see how
robust our general scientific conclusions were (e.g. regarding the efficacy of control
measures) to the particular choice of model. However, it is clearly possible to de-
velop other models. One example is to model colonization rates in the form βiC(t)
δi ,
i = 1, 2, with 0 ≤ δi ≤ 1 parameters to estimate (see e.g. [22]), so that δi = 1 gives the
full model assumption and δi = 0 gives the non-linear model assumption. However,
estimating δi accurately would require a substantial amount of data, particularly if
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there are typically only a few colonized patients on the ward at any one time. Another
option is to use something closer to non-parametric modelling, in which the coloniza-
tion rate due to k colonized patients was βk, either with or without constraints (e.g.
requiring that βk increases with k).
Our approach considers each ward separately, motivated by the fact that there is no
a priori reason to assume common transmission parameters across wards. A natural
way to relax this assumption would be to use a hierarchical model in which within-
ward parameters are themselves sampled from some hyper-distribution, and all the
data from all wards are analysed simultaneously, although in practice the amount of
data augmentation is likely to make the MCMC algorithm infeasible. Alternatively,
if data on staff movements between wards were available, it would then be possible
to model between-ward interactions in a more explicit manner.
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Table 1: Summary statistics for VRE data.
Number Number of
Percent of swab VRE+
Number Length in tests per swab tests
of of stay contact person per person
Ward patients Mean(SD) precautions Mean(SD) Mean(SD)
M1 1293 3.4(4.7) 11.4 1.2(0.8) 0.2(0.8)
M2 1018 4.4(6.4) 19.1 1.4(1.1) 0.7(1.6)
GS1 1227 3.4(5.2) 12.4 1.1(0.9) 0.3(0.9)
GS2 1030 4.0(8.3) 10.7 1.0(1.3) 0.1(0.7)
SS1 706 5.8(11.4) 12.5 1.4(1.6) 0.7(2.2)
SS2 888 4.9(9.7) 7.5 1.3(1.4) 0.3(1.8)
SS3 1097 3.8(6.4) 6.0 1.3(0.9) 0.1(0.6)
SS4 1263 3.6(5.2) 5.1 1.1(1.0) 0.1(0.5)
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Table 2: Posterior median and standard deviation of all model parameters.
Ward φ p β0 β1 β2
Full model
M1 0.12 (0.02) 0.78 (0.03) 0.0084 (0.004) 0.0023 (0.002) 0.0025 (0.003)
M2 0.23 (0.02) 0.81 (0.02) 0.0093 (0.006) 0.0028 (0.002) 0.0029 (0.002)
GS1 0.12 (0.01) 0.78 (0.03) 0.0075 (0.005) 0.0057 (0.004) 0.0034 (0.003)
GS2 0.05 (0.01) 0.49 (0.05) 0.0082 (0.005) 0.0034 (0.003) 0.0037 (0.003)
SS1 0.13 (0.02) 0.84 (0.02) 0.0038 (0.004) 0.0014 (0.002) 0.0050 (0.003)
SS2 0.05 (0.02) 0.71 (0.05) 0.0088 (0.006) 0.0065 (0.004) 0.0059 (0.004)
SS3 0.10 (0.02) 0.66 (0.05) 0.0067 (0.004) 0.0029 (0.003) 0.0048 (0.004)
SS4 0.04 (0.01) 0.68 (0.06) 0.0042 (0.002) 0.0023 (0.003) 0.0069 (0.006)
No-background model
M1 0.13 (0.01) 0.77 (0.03) 10−4 (2× 10−4) 0.0066 (0.003) 0.0054 (0.003)
M2 0.23 (0.02) 0.81 (0.02) 10−4 (1× 10−4) 0.0050 (0.003) 0.0056 (0.003)
GS1 0.13 (0.02) 0.77 (0.03) 10−4 (1× 10−4) 0.0099 (0.003) 0.0052 (0.003)
GS2 0.05 (0.01) 0.49 (0.05) 10−4 (1× 10−4) 0.0071 (0.004) 0.0079 (0.003)
SS1 0.13 (0.02) 0.84 (0.02) 10−4 (1× 10−4) 0.0015 (0.002) 0.0069 (0.002)
SS2 0.05 (0.02) 0.71 (0.04) 10−4 (1× 10−4) 0.0087 (0.004) 0.0104 (0.005)
SS3 0.11 (0.02) 0.65 (0.05) 10−4 (1× 10−4) 0.0072 (0.003) 0.0060 (0.004)
SS4 0.05 (0.01) 0.65 (0.06) 10−4 (2× 10−4) 0.0073 (0.004) 0.0074 (0.006)
Non-linear model
M1 0.12 (0.02) 0.77 (0.03) 0.0081 (0.004) 0.0040 (0.004) 0.0040 (0.004)
M2 0.23 (0.02) 0.81 (0.02) 0.0092 (0.006) 0.0050 (0.005) 0.0071 (0.006)
GS1 0.12 (0.01) 0.78 (0.03) 0.0113 (0.005) 0.0047 (0.005) 0.0048 (0.005)
GS2 0.05 (0.01) 0.49 (0.05) 0.0085 (0.005) 0.0061 (0.006) 0.0039 (0.004)
SS1 0.14 (0.02) 0.84 (0.02) 0.0048 (0.004) 0.0032 (0.004) 0.0069 (0.005)
SS2 0.05 (0.01) 0.71 (0.04) 0.0117 (0.007) 0.0081 (0.007) 0.0052 (0.006)
SS3 0.11 (0.02) 0.66 (0.05) 0.0071 (0.004) 0.0039 (0.004) 0.0057 (0.005)
SS4 0.04 (0.01) 0.68 (0.06) 0.0041 (0.002) 0.0028 (0.004) 0.0035 (0.004)
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Table 3: Observed and predicted monthly VRE prevalence.
Ward Observed Predicted
Mean (SD) Median (SD)
M1 14.8 % (2.9%) 23.3% (3.7 %)
M2 28.6 % (5.2%) 41.3% (5.0 %)
GS1 18.2 % (2.8%) 22.8% (4.1 %)
GS2 9.9 % (2.9%) 15.6% (4.0 %)
SS1 18.9 % (7.6%) 26.4% (8.6 %)
SS2 11.4 % (6.5%) 16.9% (5.5 %)
SS3 9.0 % (3.1%) 16.7% (2.8 %)
SS4 4.5 % (3.0%) 6.9% (4.7 %)
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Table 4: DIC values. Bold values indicate the preferred model.
Full model No-background Non-linear
M1 1696.88 1688.15 1716.30
M2 1990.56 1927.34 2104.64
GS1 1817.78 1815.50 1831.92
GS2 1260.86 1196.64 1343.36
SS1 948.46 955.94 939.00
SS2 1186.40 1193.44 1171.1
SS3 1498.58 1499.42 1460.34
SS4 417.64 567.82 356.66
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Figure 1: Ward M1. Number of first detected colonizations, current total detected
colonizations and number of patients on a weekly basis during the observation period.
We also show the relationship between the number of first colonizations and number
of current colonizations.
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Figure 3: Assessment of precaution measures efficacy via P (β1 > β2|y) and posterior
median of log(β1/β2) with the 95% credible intervals. The parameters β0, β1 and β2
have independent exponential prior distributions with rate 10−6 . Each diamond box
represents the overall precaution measures efficacy estimate from the meta-analysis
and its 95% confidence interval. Model indicators: 1 - Full model; 2 - No-background
model; 3 - Non-linear model. 37
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Figure 5: Full model. Number of detected colonizations at 14-day intervals. Solid lines
- number of detected colonizations in data; dashed lines - mean number of detected
colonizations based on 2000 simulations from the predictive distribution; shaded area
- 2.5% and 97.5 % percentiles from the predictive distribution.
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Figure 6: No-background model. Number of detected colonizations at 14-day in-
tervals. Solid lines - number of detected colonizations in data; dashed lines - mean
number of detected colonizations based on 2000 simulations from the predictive dis-
tribution; shaded area - 2.5% and 97.5 % percentiles from the predictive distribution.
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Figure 7: Non-linear model. Number of detected colonizations at 14-day intervals.
Solid lines - number of detected colonizations in data; dashed lines - mean number
of detected colonizations based on 2000 simulations from the predictive distribution;
shaded area - 2.5% and 97.5 % percentiles from the predictive distribution.
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